Nuclear RNA export and packaging functions of HIV-1 rev revisited

Journal of Virology

Volumn 84, Issue 13, 2010, Pages 6598-6604

  Blissenbach, Maik ^a   Grewe, Bastian ^a   Hoffmann, Bianca ^a   Brandt, Sabine ^a   Überla, Klaus ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEAR RNA; REV PROTEIN; VIRUS RNA;

ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NUCLEOCYTOPLASMIC TRANSPORT; NUCLEOTIDE SEQUENCE; PLEIOTROPY; PRIORITY JOURNAL; RNA TRANSLATION; RNA TRANSPORT; VIRUS INFECTIVITY; VIRUS REPLICATION;

CELL LINE; CELLS, CULTURED; HIV-1; HUMANS; REV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; RNA, NUCLEAR; RNA, VIRAL; VIRUS ASSEMBLY; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77953298449     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02264-09     Document Type: Article

References (48)

1. Aricescu, A. R., W. Lu, and E. Y. Jones. 2006. A time- and cost-efficient system for high-level protein production in mammalian cells. Acta Crystallogr. D 62:1243-1250.
2. Arrigo, S. J., and I. S. Chen. 1991. Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs. Genes Dev. 5:808-819.
3. Brandt, S., M. Blissenbach, B. Grewe, R. Konietzny, T. Grunwald, and K. Uberla. 2007. Rev proteins of human and simian immunodeficiency virus enhance RNA encapsidation. PLoS Pathog. 3:e54.
4. Brandt, S., T. Grunwald, S. Lucke, A. Stang, and K. Uberla. 2006. Functional replacement of the R region of simian immunodeficiency virus-based vectors by heterologous elements. J. Gen. Virol. 87:2297-2307.
5. Bray, M., S. Prasad, J. W. Dubay, E. Hunter, K. T. Jeang, D. Rekosh, and M. L. Hammarskjöld. 1994. A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. Proc. Natl. Acad. Sci. U. S. A. 91:1256-1260.
6. Butsch, M., S. Hull, Y. Wang, T. M. Roberts, and K. Boris-Lawrie. 1999. The 5′ RNA terminus of spleen necrosis virus contains a novel posttranscriptional control element that facilitates human immunodeficiency virus Rev/ RRE-independent Gag production. J. Virol. 73:4847-4855. (Pubitemid 29246745)
7. Coburn, G. A., H. L. Wiegand, Y. Kang, D. N. Ho, M. M. Georgiadis, and B. R. Cullen. 2001. Using viral species specificity to define a critical protein/ RNA interaction surface. Genes Dev. 15:1194-1205.
8. Cochrane, A. W., K. S. Jones, S. Beidas, P. J. Dillon, A. M. Skalka, and C. A. Rosen. 1991. Identification and characterization of intragenic sequences which repress human immunodeficiency virus structural gene expression. J. Virol. 65:5305-5313.
9. D'Agostino, D. M., B. K. Felber, J. E. Harrison, and G. N. Pavlakis. 1992. The Rev protein of human immunodeficiency virus type 1 promotes polysomal association and translation of gag/pol and vpu/env mRNAs. Mol. Cell. Biol. 12:1375-1386.
10. Emerman, M., R. Vazeux, and K. Peden. 1989. The rev gene product of the human immunodeficiency virus affects envelope-specific RNA localization. Cell 57:1155-1165.
11. Favaro, J. P., and S. J. Arrigo. 1997. Characterization of Rev function using subgenomic and genomic constructs in T and COS cells. Virology 228:29-38.
12. Favaro, J. P., F. Maldarelli, S. J. Arrigo, and M. G. Schmidt. 1999. Effect of rev on the cytoplasmic localization of intron-containing human immunode-ficiency virus type 1 RNA. Virology 255:237-249.
13. Felber, B. K., M. Hadzopoulou-Cladaras, C. Cladaras, T. Copeland, and G. N. Pavlakis. 1989. Rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proc. Natl. Acad. Sci. U. S. A. 86:1495-1499.
14. Fouchier, R. A., B. E. Meyer, J. H. Simon, U. Fischer, and M. H. Malim. 1997. HIV-1 infection of nondividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import. EMBO J. 16:4531-4539.
15. Gheysen, D., E. Jacobs, F. de Foresta, C. Thiriart, M. Francotte, D. Thines, and M. de Wilde. 1989. Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells. Cell 59:103-112.
16. Gramberg, T., N. Sunseri, and N. R. Landau. 2009. Accessories to the crime: recent advances in HIV accessory protein biology. Curr. HIV/AIDS Rep. 6:36-42.
17. Groom, H. C. T., E. C. Anderson, and A. M. L. Lever. 2009. Rev: beyond nuclear export. J. Gen. Virol. 90:1303-1318.
18. Grüter, P., C. Tabernero, C. von Kobbe, C. Schmitt, C. Saavedra, A. Bachi, M. Wilm, B. K. Felber, and E. Izaurralde. 1998. TAP, the human homolog of Mex67p, mediates CTE-dependent RNA export from the nucleus. Mol. Cell 1:649-659. (Pubitemid 128379243)
19. Helga-Maria, C., M. L. Hammarskjöld, and D. Rekosh. 1999. An intact TAR element and cytoplasmic localization are necessary for efficient packaging of human immunodeficiency virus type 1 genomic RNA. J. Virol. 73:4127-4135. (Pubitemid 29189858)
20. Iacampo, S., and A. Cochrane. 1996. Human immunodeficiency virus type 1 Rev function requires continued synthesis of its target mRNA. J. Virol. 70:8332-8339. (Pubitemid 26378407)
21. Jin, J., T. Sturgeon, C. Chen, S. C. Watkins, O. A. Weisz, and R. C. Montelaro. 2007. Distinct intracellular trafficking of equine infectious anemia virus and human immunodeficiency virus type 1 Gag during viral assembly and budding revealed by bimolecular fluorescence complementation assays. J. Virol. 81:11226-11235.
22. Jin, J., T. Sturgeon, O. A. Weisz, W. Mothes, and R. C. Montelaro. 2009. HIV-1 matrix dependent membrane targeting is regulated by Gag mRNA trafficking. PLoS One 4:e6551.
23. Jin, L., B. W. Guzik, Y.-C. Bor, D. Rekosh, and M.-L. Hammarskjöld. 2003. Tap and NXT promote translation of unspliced mRNA. Genes Dev. 17:3075-3086.
24. Karacostas, V., K. Nagashima, M. A. Gonda, and B. Moss. 1989. Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector. Proc. Natl. Acad. Sci. U. S. A. 86:8964-8967.
25. Kimura, T., I. Hashimoto, M. Nishikawa, and J. I. Fujisawa. 1996. A role for Rev in the association of HIV-1 gag mRNA with cytoskeletal beta-actin and viral protein expression. Biochimie 78:1075-1080.
26. Kotsopoulou, E., V. N. Kim, A. J. Kingsman, S. M. Kingsman, and K. A. Mitrophanous. 2000. A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene. J. Virol. 74:4839-4852.
27. Lucke, S., T. Grunwald, and K. Uberla. 2005. Reduced mobilization of Rev-responsive element-deficient lentiviral vectors. J. Virol. 79:9359-9362.
28. Malim, M. H., and B. R. Cullen. 1993. Rev and the fate of pre-mRNA in the nucleus: implications for the regulation of RNA processing in eukaryotes. Mol. Cell. Biol. 13:6180-6189.
29. Malim, M. H., J. Hauber, R. Fenrick, and B. R. Cullen. 1988. Immunode-ficiency virus rev trans-activator modulates the expression of the viral regulatory genes. Nature 335:181-183.
30. Malim, M. H., and M. Emerman. 2008. HIV-1 accessory proteins-ensuring viral survival in a hostile environment. Cell Host Microbe 3:388-398.
31. Michael, N. L., S. A. Herman, S. Kwok, K. Dreyer, J. Wang, C. Christopherson, J. P. Spadoro, K. K. Young, V. Polonis, F. E. McCutchan, J. Carr, J. R. Mascola, L. L. Jagodzinski, and M. L. Robb. 1999. Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes. J. Clin. Microbiol. 37:2557-2563.
32. Moore, M. D., O. A. Nikolaitchik, J. Chen, M.-L. Hammarskjöld, D. Rekosh, and W.-S. Hu. 2009. Probing the HIV-1 genomic RNA trafficking pathway and dimerization by genetic recombination and single virion analyses. PLoS Pathog. 5:e1000627.
33. Nappi, F., R. Schneider, A. Zolotukhin, S. Smulevitch, D. Michalowski, J. Bear, B. K. Felber, and G. N. Pavlakis. 2001. Identification of a novel posttranscriptional regulatory element by using a rev- and RRE-mutated human immunodeficiency virus type 1 DNA proviral clone as a molecular trap. J. Virol. 75:4558-4569.
34. Nekhai, S., and K.-T. Jeang. 2006. Transcriptional and post-transcriptional regulation of HIV-1 gene expression: role of cellular factors for Tat and Rev. Future Microbiol. 1:417-426.
35. Perales, C., L. Carrasco, and M. E. Gonzalez. 2005. Regulation of HIV-1 env mRNA translation by Rev protein. Biochim. Biophys. Acta 1743:169-175.
36. Pollard, V. W., and M. H. Malim. 1998. The HIV-1 Rev protein. Annu. Rev. Microbiol. 52:491-532.
37. Schneider, R., M. Campbell, G. Nasioulas, B. K. Felber, and G. N. Pavlakis. 1997. Inactivation of the human immunodeficiency virus type 1 inhibitory elements allows Rev-independent expression of Gag and Gag/protease and particle formation. J. Virol. 71:4892-4903. (Pubitemid 27258156)
38. Schwartz, S., M. Campbell, G. Nasioulas, J. Harrison, B. K. Felber, and G. N. Pavlakis. 1992. Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression. J. Virol. 66:7176-7182.
39. Schwartz, S., B. K. Felber, and G. N. Pavlakis. 1992. Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein. J. Virol. 66:150-159.
40. Suhasini, M., and T. R. Reddy. 2009. Cellular proteins and HIV-1 Rev function. Curr. HIV Res. 7:91-100.
41. Swanson, C. M., and M. H. Malim. 2006. Retrovirus RNA trafficking: from chromatin to invasive genomes. Traffic 7:1440-1450.
42. Swanson, C. M., B. A. Puffer, K. M. Ahmad, R. W. Doms, and M. H. Malim. 2004. Retroviral mRNA nuclear export elements regulate protein function and virion assembly. EMBO J. 23:2632-2640.
43. Trono, D., and D. Baltimore. 1990. A human cell factor is essential for HIV-1 Rev action. EMBO J. 9:4155-4160. (Pubitemid 20380008)
44. Wagner, R., M. Graf, K. Bieler, H. Wolf, T. Grunwald, P. Foley, and K. Uberla. 2000. Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors. Hum. Gene Ther. 11:2403-2413.
45. Ward, A. M., D. Rekosh, and M.-L. Hammarskjold. 2009. Trafficking through the Rev/RRE pathway is essential for efficient inhibition of human immunodeficiency virus type 1 by an antisense RNA derived from the envelope gene. J. Virol. 83:940-952.
46. Wiegand, H. L., G. A. Coburn, Y. Zeng, Y. Kang, H. P. Bogerd, and B. R. Cullen. 2002. Formation of Tap/NXT1 heterodimers activates Tap-dependent nuclear mRNA export by enhancing recruitment to nuclear pore complexes. Mol. Cell. Biol. 22:245-256.
47. Yi, R., H. P. Bogerd, and B. R. Cullen. 2002. Recruitment of the Crm1 nuclear export factor is sufficient to induce cytoplasmic expression of incompletely spliced human immunodeficiency virus mRNAs. J. Virol. 76:2036-2042.
48. Zufferey, R., J. E. Donello, D. Trono, and T. J. Hope. 1999. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J. Virol. 73:2886-2892. (Pubitemid 29135675)